Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD: The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012, 36: 237-248. 10.1016/j.canep.2012.02.007.
Article
PubMed
Google Scholar
Cleator S, Heller W, Coombes RC: Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007, 8: 235-244. 10.1016/S1470-2045(07)70074-8.
Article
PubMed
Google Scholar
Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M: Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer. J Med Chem. 1996, 39: 3461-3469. 10.1021/jm950938g.
Article
CAS
PubMed
Google Scholar
Reiners JJ, Clift R, Mathieu P: Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor. Carcinogenesis. 1999, 20: 1561-1566. 10.1093/carcin/20.8.1561.
Article
CAS
PubMed
Google Scholar
Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubinstein L, Plowman J, Boyd MR: Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst. 1989, 81: 1088-1092. 10.1093/jnci/81.14.1088.
Article
CAS
PubMed
Google Scholar
Weinstein JN, Myers TG, O’Connor PM, Friend SH, Fornace AJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE, Paull KD: An information-intensive approach to the molecular pharmacology of cancer. Science. 1997, 275: 343-349. 10.1126/science.275.5298.343.
Article
CAS
PubMed
Google Scholar
Kuffel MJ, Schroeder JC, Pobst LJ, Naylor S, Reid JM, Kaufmann SH, Ames MM: Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2. Mol Pharmacol. 2002, 62: 143-153. 10.1124/mol.62.1.143.
Article
CAS
PubMed
Google Scholar
Loaiza-Pérez AI, Kenney S, Boswell J, Hollingshead M, Alley MC, Hose C, Ciolino HP, Yeh GC, Trepel JB, Vistica DT, Sausville EA: Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Mol Cancer Ther. 2004, 3: 715-725. 10.4161/cbt.3.8.966.
Article
PubMed
Google Scholar
Stark K, Burger A, Wu J, Shelton P, Polin L, Li J: Reactivation of estrogen receptor α by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor. PLoS One. 2013, 8: e74525-10.1371/journal.pone.0074525.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cushman M, Nagarathnam D: Cytotoxicities of some flavonoid analogues. J Nat Prod. 1991, 54: 1656-1660. 10.1021/np50078a027.
Article
CAS
PubMed
Google Scholar
Akama T, Ishida H, Shida Y, Kimura U, Gomi K, Saito H, Fuse E, Kobayashi S, Yoda N, Kasai M: Design and synthesis of potent antitumor 5,4′-diaminoflavone derivatives based on metabolic considerations. J Med Chem. 1997, 40: 1894-1900. 10.1021/jm9700326.
Article
CAS
PubMed
Google Scholar
Akama T, Ishida H, Kimura U, Gomi K, Saito H: Structure-activity relationships of the 7-substituents of 5,4′-diamino-6,8,3′-trifluoroflavone, a potent antitumor agent. J Med Chem. 1998, 41: 2056-2067. 10.1021/jm970728z.
Article
CAS
PubMed
Google Scholar
Ferriola PC, Cody V, Middleton E: Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol. 1989, 38: 1617-1624. 10.1016/0006-2952(89)90309-2.
Article
CAS
PubMed
Google Scholar
Yamashita Y, Kawada S, Nakano H: Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol. 1990, 39: 737-744. 10.1016/0006-2952(90)90153-C.
Article
CAS
PubMed
Google Scholar
Shi Q, Chen K, Morris-Natschke SL, Lee KH: Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents. Curr Pharm Des. 1998, 4: 219-248.
CAS
PubMed
Google Scholar
Lu YF, Santostefano M, Cunningham BD, Threadgill MD, Safe S: Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists. Biochem Pharmacol. 1996, 51: 1077-1087. 10.1016/0006-2952(96)00063-9.
Article
CAS
PubMed
Google Scholar
Loaiza-Pérez AI, Kenney S, Boswell J, Hollingshead M, Hose C, Linehan WM, Worrell R, Rubinstein L, Sausville EA, Vistica DT: Sensitivity of renal cell carcinoma to aminoflavone: role of CYP1A1. J Urol. 2004, 171: 1688-1697. 10.1097/01.ju.0000108860.03389.1b.
Article
PubMed
Google Scholar
Ciolino HP, Dankwah M, Yeh GC: Resistance of MCF-7 cells to dimethylbenz (a) anthracene-induced apoptosis is due to reduced CYP1A1 expression. Int J Oncol. 2002, 21: 385-391.
CAS
PubMed
Google Scholar
Callero MA, Loaiza-Pérez AI: The role of aryl hydrocarbon receptor and crosstalk with estrogen receptor in response of breast cancer cells to the novel antitumor agents benzothiazoles and aminoflavone. Int J Breast Cancer. 2011, 2011: 923250-
Article
PubMed
PubMed Central
Google Scholar
Meng LH, Shankavaram U, Chen C, Agama K, Fu HQ, Gonzalez FJ, Weinstein J, Pommier Y: Activation of aminoflavone (NSC 686288) by a sulfotransferase is required for the antiproliferative effect of the drug and for induction of histone gamma-H2AX. Cancer Res. 2006, 66: 9656-9664. 10.1158/0008-5472.CAN-06-0796.
Article
CAS
PubMed
Google Scholar
Zheng Q, Sha X, Liu J, Heath E, Lorusso P, Li J: Association of human cytochrome P450 1A1 (CYP1A1) and sulfotransferase 1A1 (SULT1A1) polymorphisms with differential metabolism and cytotoxicity of aminoflavone. Mol Cancer Ther. 2010, 9: 2803-2813. 10.1158/1535-7163.MCT-10-0597.
Article
CAS
PubMed
Google Scholar
Meng LH, Kohlhagen G, Liao ZY, Antony S, Sausville E, Pommier Y: DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cells. Cancer Res. 2005, 65: 5337-5343. 10.1158/0008-5472.CAN-05-0003.
Article
CAS
PubMed
Google Scholar
McLean L, Soto U, Agama K, Francis J, Jimenez R, Pommier Y, Sowers L, Brantley E: Aminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells. Int J Cancer. 2008, 122: 1665-1674.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meng LH, Meng Z, Miao ZH, Veenstra TD, Pommier Y: Cytokeratin-RNA cross-linking mediated by the antitumor aminoflavone, 5-amino-2,3-fluorophenyl-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one. J Pharmacol Exp Ther. 2008, 325: 674-680. 10.1124/jpet.108.137802.
Article
CAS
PubMed
Google Scholar
Callero MA, Suárez GV, Luzzani G, Itkin B, Nguyen B, Loaiza-Perez AI: Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment. Int J Oncol. 2012, 41: 125-134.
CAS
PubMed
Google Scholar
Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ: Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol. 1996, 140: 173-179. 10.1006/taap.1996.0210.
Article
CAS
PubMed
Google Scholar
Denison MS, Nagy SR: Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol. 2003, 43: 309-334. 10.1146/annurev.pharmtox.43.100901.135828.
Article
CAS
PubMed
Google Scholar
Probst MR, Reisz-Porszasz S, Agbunag RV, Ong MS, Hankinson O: Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol Pharmacol. 1993, 44: 511-518.
CAS
PubMed
Google Scholar
Abel J, Haarmann-Stemmann T: An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol Chem. 2010, 391: 1235-1248.
Article
CAS
PubMed
Google Scholar
Terzuoli E, Puppo M, Rapisarda A, Uranchimeg B, Cao L, Burger AM, Ziche M, Melillo G: Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion. Cancer Res. 2010, 70: 6837-6848. 10.1158/0008-5472.CAN-10-1075.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gioanni J, Le François D, Zanghellini E, Mazeau C, Ettore F, Lambert JC, Schneider M, Dutrillaux B: Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. Br J Cancer. 1990, 62: 8-13. 10.1038/bjc.1990.219.
Article
CAS
PubMed
PubMed Central
Google Scholar
Postlind H, Vu TP, Tukey RH, Quattrochi LC: Response of human CYP1-luciferase plasmids to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol. 1993, 118: 255-262. 10.1006/taap.1993.1031.
Article
CAS
PubMed
Google Scholar
Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002, 296: 550-553. 10.1126/science.1068999.
Article
CAS
PubMed
Google Scholar
Kalmes M, Neumeyer A, Rio P, Hanenberg H, Fritsche E, Blömeke B: Impact of the arylhydrocarbon receptor on eugenol- and isoeugenol-induced cell cycle arrest in human immortalized keratinocytes (HaCaT). Biol Chem. 2006, 387: 1201-1207.
Article
CAS
PubMed
Google Scholar
Gluschnaider U, Hidas G, Cojocaru G, Yutkin V, Ben-Neriah Y, Pikarsky E: beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor. PLoS One. 2010, 5: e9060-10.1371/journal.pone.0009060.
Article
PubMed
PubMed Central
Google Scholar
Wiznerowicz M, Trono D: Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol. 2003, 77: 8957-8961. 10.1128/JVI.77.16.8957-8951.2003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992, 89: 5547-5551. 10.1073/pnas.89.12.5547.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deuschle U, Meyer WK, Thiesen HJ: Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol. 1995, 15: 1907-1914.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stegeman JJ, Hahn ME, Weisbrod R, Woodin BR, Joy JS, Najibi S, Cohen RA: Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells. Mol Pharmacol. 1995, 47: 296-306.
CAS
PubMed
Google Scholar
Matsumura F: The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochem Pharmacol. 2009, 77: 608-626. 10.1016/j.bcp.2008.10.013.
Article
CAS
PubMed
Google Scholar
Blanchard JM: Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues. Biochem Pharmacol. 2000, 60: 1179-1184. 10.1016/S0006-2952(00)00384-1.
Article
CAS
PubMed
Google Scholar
Reinicke KE, Kuffel MJ, Goetz MP, Ames MM: Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells. Cancer Chemother Pharmacol. 2010, 66: 575-583. 10.1007/s00280-009-1198-z.
Article
CAS
PubMed
Google Scholar
Dong B, Cheng W, Li W, Zheng J, Wu D, Matsumura F, Vogel CF: FRET analysis of protein tyrosine kinase c-Src activation mediated via aryl hydrocarbon receptor. Biochim Biophys Acta. 1810, 2011: 427-431.
Google Scholar
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.
Article
CAS
PubMed
Google Scholar
Hu X, Stern HM, Ge L, O’Brien C, Haydu L, Honchell CD, Haverty PM, Peters BA, Wu TD, Amler LC, Chant J, Stokoe D, Lackner MR, Cavet G: Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res. 2009, 7: 511-522. 10.1158/1541-7786.MCR-08-0107.
Article
CAS
PubMed
Google Scholar
Chuang HC, Kapuriya N, Kulp SK, Chen CS, Shapiro CL: Differential anti-proliferative activities of poly (ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells. Breast Cancer Res Treat. 2012, 134: 649-659. 10.1007/s10549-012-2106-5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seitz S, Wassmuth P, Plaschke J, Schackert HK, Karsten U, Santibanez-Koref MF, Schlag PM, Scherneck S: Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Genes Chromosomes Cancer. 2003, 37: 29-35. 10.1002/gcc.10196.
Article
CAS
PubMed
Google Scholar